HIV Articles  
Back 
 
 
HIV-Associated Neurocognitive Disorders in the Era of Potent Antiretroviral Therapy: risk factors/prevalence, CSF HIV-RNA, HCV, ART PK/penetration, assessment tools
 
 
  Reported by Jules Levin
 
Scott Letendre, M.D.
 
Associate Professor of Medicine
University of California, San Diego
 
11 September 2009
49th Interscience Conference on Antimicrobial
Agents and Chemotherapy - Complications Workshop Pre-ICAAC
San Francisco, California
 
In this slide presentation Scott Letendre reviews:
- Model of HIV neuropathogenesis
- Definition of neurocognitive disorders and sliding scales of disorders
- Prevalence of neurocognitive disorders in USA and globally
- Consequences in daily living for patients with cognitive disorders
- Risk factors for cognitive disorders
- HIV viral loads in CSF compared to plasma and disconnect, where CSF viral load can be detectable despite undetectable plasma HIV viral load
- The effect of nadir CD4
- HCV and the brain
- PK of ART drug penetration: PIs, NNRTIs, NRTIs
- Scoring penetration effectives of HAART and specific ARTs (more research needed)
- Tools to assess patient functioning and neurologic disorders, patient survey assessments, brief neurological testing that can be performed in the clinic and in studies
 
Development of HIV-associated dementia (HAND) is associated with HIV, insulin resistance, hepatitis C, bacterial translocation, and a history of cocaine or methamphetamine use. Patients with low CD4 nadir are at greater risk for developing HAND, and patients with HAND are more likely to have higher hsCRP levels (inflammation).
 
4% of patients in a study (CHARTER), had detectable viral loads in CSF (>50 c/ml) even though viral load was undetectable in plasma. But, 31% with detectable viral load in plasma had detectable CSF viral load (>50 c/ml), giving I think a suggestion of the magnitude for potential cognitive impairment that can occur for patients with detectable plasma viral load and the importance and implications of achieving undetectable plasma viral load. Of note, 26% of patients with >2 copies/ml in plasma had > 2 copies in CSF and this was associated with higher scores of cognitive impairment.
 
HCV & AIDS appears to make neurologic impairment worse, see table below.
 
In graphs below the CSF penetration of PIs, NNRTIs and NRTIs are shown including the CSF penetration of darunavir and raltegravir presented at ICAAC 2009 in September 2009.
 

image002.gif

image004.gif

image006.gif

image008.gif

image010.gif

"cognitive impairment in HIV is a significant source of disability in daily life. Thus, patients with diminished NP abilities were more likely to report cognitive problems, had objective difficulty with standardized tasks assessing ability to manage complex medication regimens, manage finances, and prepare meals, and showed a higher rate of job loss or diminished performance at a jobs they previously were able to perform well." Scott Letendre
 

image012.gif

image014.gif

image016.gif

image018.gif

image020.gif

image022.gif

image024.gif

image026.gif

image028.gif

image030.gif

This slide depicts the components of the blood-brain barrier. These include interparenchymal capillaries, with unique tight junctions preventing the easy passage of substances from the intravascular space to the CNS. One also sees the surrounding structures, including astrocytic foot processes.
 

image032.gif

image034.gif

image036.gif

does-1.gif

image040.gif

The data above and the reported RTV concentrations suggested that both the Pgp and CYP3A4 inhibition by RTV may play a significant role in enhancing the systemic and tissue exposure to DPC in humans.
 
Solon EG, Balani SK, Luo G, Yang TJ, Haines PJ, Wang L, Demond T, Diamond S, Christ DD, Gan LS, Lee FW. Related Articles, Links
 
Interaction of ritonavir on tissue distribution of a [(14)c]L-valinamide, a potent human immunodeficiency virus-1 protease inhibitor, in rats using quantitative whole-body autoradiography. Drug Metab Dispos. 2002 Nov;30(11):1164-9.
 
Huisman, M., Smit, J., Hoetelmans, R., Wiltshire, H., Beijnen, J., and Schinkel, A.
 
The role of P-glycoprotein in oral bioavailability, brain and fetal penetration of the HIV protease inhibitor saquinavir. in Fifth International Congress on Drug Therapy in HIV Infection. 2000. Glasgow, United Kingdom.

image042.gif

image044.gif

image046.gif

image048.gif

image050.gif

image052.gif

image054.gif

image056.gif

image058.gif

image060.gif

Letendre S, et al. 13th CROI, 2006, Abstract 74

image062.gif

Letendre S, et al. 13th CROI, 2006, Abstract 74
Fig 2. Reduction (improvement) in GDS among subjects with and without suppressed CSF HIV RNA viral load at followup. Box-and-whisker plots show the median (center line), interquartile range (box), and 5th and 95th percentiles (whiskers). GDS = global deficit score; CSF = cerebrospinal fluid; HIV = human immunodeficiency virus.

image064.gif

image066.gif

Letendre S, et al. 16th CROI 2009, Abstract 484b

image068.gif

image070.gif

image072.gif

image074.gif

image076.gif

image078.gif

image080.gif

image082.gif

image084.gif

image086.gif

image088.gif

image090.gif

image092.gif

image094.gif

image096.gif

image098.gif

image100.gif

image102.gif

image104.gif

image106.gif

 
 
 
 
  iconpaperstack view older Articles   Back to Top   www.natap.org